홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

N-(5-{2-[ethyl-(2,2,2-trifluoro-acetyl)-amino]-propyl}-benzo[1,3]dioxol-2-ylmethyl)-succinamic acid 2,5-dioxo-pyrrolidin-1-yl ester → Methylenedioxyethamphetamine

HRID 2212468
인쇄

반응식

HRID 2212468 반응식
O=C1CCC(=O)N1OC(=O)CCC(NC[CH:16]1[O:20][C:19]2[CH:21]=[CH:22][C:23]([CH2:25][CH:26]([N:28](CC)[C:29](=O)[C:30](F)(F)F)[CH3:27])=[CH:24][C:18]=2[O:17]1)=O>P([O-])([O-])([O-])=O.[K+].[K+].[K+].CN(C=O)C>[CH3:30][CH2:29][NH:28][CH:26]([CH2:25][C:23]1[CH:22]=[CH:21][C:19]2[O:20][CH2:16][O:17][C:18]=2[CH:24]=1)[CH3:27]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 1

HCID 86595989N-(5-{2-[ethyl-(2,2,2-trifluoro-acetyl)-amino]-propyl}-benzo[1,3]dioxol-2-ylmethyl)-succinamic acid 2,5-dioxo-pyrrolidin-1-yl ester

생성물 1

HCID 105039Methylenedioxyethamphetamine

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 62657Potassium Phosphate, Tribasic용매

실험 절차

MDEA-BSA conjugate 36 was synthesized as described in copending, commonly assigned U.S. Ser. No. 10/622,254 filed contemporaneously herewith. A solution of 500 mg of bovine serum albumin (BSA) in 6.7 mL of 50 mM potassium phosphate (pH 7.5) was cooled in an ice-bath. To the solution was added 8.5 mL of DM50 dropwise, and the reaction mixture was maintained below room temperature. To the protein solution was added a solution of 12 mg (0.022 mmol) of N-(5-{2-[ethyl-(2,2,2-trifluoro-acetyl)-amino]-propyl}-benzo[1,3]dioxol-2-ylmethyl)-succinamic acid 2,5-dioxo-pyrrolidin-1-yl ester (compound 2L in U.S. Ser. No. 10/622,254) in 1.5 mL of anhydrous DMF dropwise. The reaction mixture was allowed to stir at room temperature 48 hours. The resulting conjugate was placed in a dialysis tube (10,000 MW cut-off) and was dialyzed in 1 L of 70% DMSO in 50 mM potassium phosphate (pH 7.5, 3 changes, at least 3 hours each), 1 L of 50% DMSO in 50 mM potassium phosphate (at least 3 hours), 1 L of 30% DMSO in 50 mM potassium phosphate (at least 3 hours), 1 L of 10% DMSO in 50 mM potassium phosphate (at least 3 hours) at room temperature. The trifluoroacetamido group of the conjugate was deprotected by dialysis of the resulting conjugate against 10% ammonium hydroxide for 3 days (1 L each for approximately 24 hours each), followed by 6 changes with 50 mM potassium phosphate (pH 7.5) at 4° C. (1 L each). The protein concentration was determined to be 7.12 mg/mL using BioRad Coomassie blue protein assay (Bradford, M., Anal. Biochem. 72:248, 1976). A total of 45 mL of the conjugate was obtained.

후처리

  1. additionTo the solution was added 8.5 mL of DM50 dropwise, and the reaction mixture
  2. temperaturewas maintained below room temperature
  3. customThe resulting conjugate was placed in a dialysis tube
  4. custom(10,000 MW cut-off) and was dialyzed in 1 L of 70% DMSO in 50 mM potassium phosphate (pH 7.5, 3 changes, at least 3 hours each), 1 L of 50% DMSO in 50 mM potassium phosphate (at least 3 hours), 1 L of 30% DMSO in 50 mM potassium phosphate (at least 3 hours)
  5. custom1 L of 10% DMSO in 50 mM potassium phosphate (at least 3 hours)
  6. customat room temperature
  7. customThe trifluoroacetamido group of the conjugate was deprotected by dialysis of the resulting conjugate against 10% ammonium hydroxide for 3 days (1 L each for approximately 24 hours each),
  8. customfollowed by 6 changes with 50 mM potassium phosphate (pH 7.5) at 4° C.
  9. concentrationThe protein concentration
  10. customA total of 45 mL of the conjugate was obtained

출처 및 근거

ORD 기록
ord-91bfb8dc7ac541e9ae035ad70237f987
출처 데이터셋
uspto-grants-2006_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07101980B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트